Sustained low-efficiency dialysis in the ICU: Cost, anticoagulation, and solute removal

Kidney International

Volumn 70, Issue 5, 2006, Pages 963-968

  Berbece, A N ^a   Richardson, R M A ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Acute renal failure; Anticoagulation; Economic analysis; Hemodialysis; Urea modeling

Indexed keywords

CITRIC ACID; HEPARIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEALTH CARE COST; HEMODIALYSIS; HEMOFILTRATION; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; KIDNEY CLEARANCE; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOLUTE; SUSTAINED LOW EFFICIENCY DIALYSIS; TREATMENT DURATION;

ADULT; AGED; ANTICOAGULANTS; BLOOD COAGULATION; COSTS AND COST ANALYSIS; CRITICAL CARE; FEMALE; HEMOFILTRATION; HUMANS; INTENSIVE CARE UNITS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; UREA;

EID: 33747818239     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001700     Document Type: Article

References (15)

1. Evanson JA, Himmelfarb J, Wingard R et al. Prescribed versus delivered dialysis dose in acute renal failure patients. Am J Kidney Dis 1998; 32: 731-738.
2. Manns B, Doig CJ, Lee H et al. Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med 2003; 31: 449-455.
3. Kellum JA, Angus DC, Johnson J et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intens Care Med 2002; 28: 29-37.
4. Kumar VA, Craig M, Depner TA, Yeun JY. Extended daily dialysis: a new approach to renal replacement failure in the intensive care unit. Am J Kidney Dis 2000; 36: 294-300.
5. Marshall MR, Golper TA, Shaver MJ et al. Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int 2001; 60: 777-785.
6. Marshall MR, Ma T, Galler D et al. Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequate therapy. Nephrol Dial Transplant 2004; 19: 877-884.
7. Kielstein JT, Kretschmer U, Ernst T et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis 2004; 43: 342-349.
8. Ricci Z, Ronco C, D'Amico G et al. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol Dial Transplant 2006; 21: 690-696.
9. Marshall MR, Golper TA, Shaver MJ et al. Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy. Am J Kidney Dis 2002; 39: 556-570.
10. Casino FG, Marshall MR. Simple and accurate quantification of dialysis in acute renal failure patients during either urea non-steady state or treatment with irregular or continuous schedules. Nephrol Dial Transplant 2004; 19: 1454-1461.
11. Ronco C, Bellomo R, Homal P. Effects of different dose in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet 2000; 356: 26-30.
12. Schiffl H, Lang S, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346: 306-310.
13. Liao Z, Shang W, Hardy PA et al. Kinetic comparisons of different acute dialysis therapies. Artif Organs 2003; 27: 802-807.
14. Renal Study. http://www.clinicaltrials.gov/ct/show/NCT00076219.
15. Tobe SW, Aujla P, Walele AA et al. A novel regional citrate anticoagulation protocol for CRRT using only commercially available solutions. J Crit Care 2003; 18: 121-129.